In 2024, SIROMED PHARMA, UAB had revenue of 11.4 million EUR.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 11,4m € | 0 € | 0 € -100.0% |
Profit | - | - | - |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | 1,5m € | - -100.0% | 1,3m € |
Employees | - | - | - |
Overall rating | B+75/100 |
Financial health | 70/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 60/100 |
| Overall risk | Low |
No risk flags | |
Possible tax debts | |
No financial data available | |
Regular report filing | |
| Description | Registered |
|---|---|
| CEO (Male) |
SIROMED PHARMA, UAB is located at Vilnius, Ozo g. 25, LT-07150, LT-LT-07150.
The shareholders of SIROMED PHARMA, UAB include 1 Lithuanian legal entities. View ownership details →
Yes, SIROMED PHARMA, UAB is registered as an active VAT payer with VAT number LT100009539211.
SIROMED PHARMA, UAB was founded on May 11, 2015. The company has been operating for 11 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 11 years | 119 - 123 | 33% | |
Net revenue | 11 422 000,00 € | 22 - 26 | 87% | |
Equity | 1 472 000,00 € | 6 - 10 | 84% | |
Registered capital | 110 000,00 € | - | 90% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Lithuanian register of legal entities.